Current Trials

CM4919s Type 1 or 2 Diabetes (Recruitment for this trial is closed)

 Your Health Clinics - SA, Woodville

Diabetic Macular Edema
Diabetic retinopathy is a complication of diabetes in which high blood sugar levels cause damage to retinal blood vessels in the eyes. It is the main cause of all vision loss from age 20-74 and is detectable in one third of all diabetics worldwide.

Eligibility requirements

  • Age: 18-75 years inclusive
  • Sex: Males and females
  • Weight: >50kg
  • Medication: Stable medication history
  • Medical History: Type 1 or Type 2 Diabetes with Diabetic macular edema
  • Smoking History: Non-Smoker

Overnight Stays

  • Nil

Outpatient Visits

  • The study consists of 3 periods for all participants: screening, treatment and follow-up. Screening may occur across one or two visits, the treatment period is 28 days with a follow up period of another 28 days. There is also a potential, additional, 8-week opt-in treatment period with a follow up period of 28 days.


  • Reimbursement for reasonable travel/parking expenses approx. $50 per visit.

Recruitment for this trial is closed.